Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016-2019 data.

导出 LinkOut

翻译打印收藏纠错

第一作者： Omar,Qureshi

第一单位： Yale School of Medicine, New Haven, CT, USA.

作者： Omar,Qureshi ^[1] ; Reshma,Ramachandran ^[2] ; Joseph S,Ross ^[3]

作者单位： Yale School of Medicine, New Haven, CT, USA. ^[1] Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. ^[2] Yale Collaboration for Regulatory Rigor, Integrity and Transparency (CRRIT), Yale School of Medicine, New Haven, CT, USA. ^[3] Department of Health Policy and Management, Yale School of Public Health; and Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT, USA. ^[4]

关键词 Centers for Medicare & Medicaid Services Inflation Reduction Act Medicare Drug Price Negotiation Program Medicare Parts B and D Medicare drug policy

DOI 10.1080/20523211.2024.2312374

PMID 38434725

发布时间 2024-03-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of pharmaceutical policy and practice

2024年17卷1期

2312374页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016-2019 data.

Journal of pharmaceutical policy and practice

相似文献

Journal of pharmaceutical policy and practice

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016-2019 data.

Journal of pharmaceutical policy and practice

相似文献

Journal of pharmaceutical policy and practice

相关期刊

检索历史清除